| Catalog No. |
Size |
Price |
Figures |
|---|
Z00012-1 mg
| 1 mg | $ 420.00 |
References:
- Olson JK, Grose C. Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol. Feb 1998;72(2):1542-51.
- Moffat J, Mo C et al. Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.
J Virol. Nov 2004;78(22):12406-15.
- Mo C, Schneeberger EE, Arvin AM. Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells. J Virol. Dec 2000;74(23):11377-87.
|
|---|
| Full Name | | Varicella Zoster Virus (VZV) gE |
|
| Abbreviated Name-1 | VZVgE; varicella-zoster virus glycoprotein E |
|---|
| Description | Varicella Zoster Virus (VZV) gE is an E. coli-derived recombinant. The protein contains the VZV gE immunodominant regions. Varicella-zoster virus (VZV) glycoprotein E (gE) is essential for VZV replication. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 50% glycerol |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of VZV-infected individuals |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of VZV with minimal specificity problems |
|---|
